Skip to main content
. 2017 Nov 29;7:16585. doi: 10.1038/s41598-017-16828-x

Table 4.

Demographic and clinical characteristics of the MS patients included in pSTAT1 experiments.

Female/male 14/4
Age (years) 39,7 ( ± 13.7)
MS duration (years) 11.7 ( ± 14.5)
EDSS 1.5 ( ± 1.1)
IFNß treatment (Avonex/Betaferon/Rebif) (1/3/14)
NAbs titter (high/intermediate/low) (6/1/3)

MS: multiple sclerosis; EDSS: Expanded Disability Status Scale.

Age, MS duration and EDSS are presented as mean ± standard deviation.